Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |